Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased Oversight
White Paper for the Center for Health & Pharmaceutical Law & Policy, Seton Hall Law School
62 Pages
Posted: 3 Dec 2009
Last revised: 11 Feb 2014
Seton Hall School of Law; Seton Hall University - Center for Health & Pharmaceutical Law & Policy
Seton Hall University School of Law
Seton Hall University - Center for Health & Pharmaceutical Law & Policy
affiliation not provided to SSRN
University of Chicago - MacLean Center for Clinical Medical Ethics; New York State Task Force on Life and the Law; DePaul University - College of Law
Center for Health & Pharmaceutical Law & Policy; Seton Hall School of Law
Seton Hall University - Center for Health & Pharmaceutical Law & Policy
Date Written: November 30, 2009
Abstract
This White Paper makes several policy recommendations to eliminate or manage the conflicts of interest that arise pursuant to the compensation arrangements between investigators and their institutions with drug and medical device manufacturers as they affect the recruitment and enrollment of human research subjects in clinical trials. The paper seeks to accomplish overall financial neutrality as between treatment and research, so that physicians' decisions regarding inclusion of patients in clinical trials is unaffected by their own financial interests.
Keywords: conflict of interest, pharmaceutical, clinical trials
Suggested Citation:
Suggested Citation
Boozang, Kathleen and Coleman, Carl H. and Miller, Tracy E. and Greenwood, Kate and Koch, Valerie Gutmann and Handler-Hutchinson, Simone and Finizio, Catherine, Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased Oversight (November 30, 2009). White Paper for the Center for Health & Pharmaceutical Law & Policy, Seton Hall Law School. Available at SSRN: https://ssrn.com/abstract=1515762 or http://dx.doi.org/10.2139/ssrn.1515762
